Yixuan Yang
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The brain-gut-skin axis in inflammatory and disfiguring skin diseases: mechanistic insights, clinical correlations, and therapeutic strategies.
Journal: Frontiers in immunology
Published: November 01, 2025
Vitiligo secondary to immunosuppressants: a pharmacovigilance study of the FDA Adverse Event Reporting System.
Journal: Frontiers in immunology
Published: September 17, 2025
Real world pharmacovigilance study of antineoplastic drug related vitiligo risks.
Journal: Scientific reports
Published: November 23, 2024
Drug-induced dermatomyositis: a pharmacovigilance study of the FDA adverse event reporting system.
Journal: Frontiers in pharmacology
Published: November 12, 2024
Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system.
Journal: Frontiers in medicine
Published: November 02, 2024
The potential of cellular homing behavior in tumor immunotherapy: from basic discoveries to clinical applications of immune, mesenchymal stem, and cancer cell homing.
Journal: Frontiers in immunology
Published: September 13, 2024
Polyphenols targeting multiple molecular targets and pathways for the treatment of vitiligo.
Journal: Frontiers in immunology
Published: February 17, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026